Inmed Pharmaceuticals Inc.
INM
Revenue
1.24M
▲338.34k▲37.52%
3 Months ChangeAssets
11.82M
▼-3.43M▼-22.50%
6 Months ChangeLiabilities
2.62M
▲133.42k▲5.37%
6 Months ChangeFree Cash Flow
-2.90M
▼-506.37k▼-21.12%
24 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-28
Form 8-K
ID: 0001213900-24-091172
2024-10-24
Form 8-K
ID: 0001213900-24-090365
2024-10-23
Form 8-K
ID: 0001213900-24-089887
2024-09-30
Form 8-K
ID: 0001213900-24-083203
2024-09-26
Form 8-K
ID: 0001213900-24-082247
2024-09-20
Form 8-K
ID: 0001213900-24-080662
2024-08-21
Form 8-K
ID: 0001213900-24-071386
2024-08-20
Form 8-K
ID: 0001213900-24-071061
2024-07-30
Form 8-K
ID: 0001013762-24-002578
2024-06-28
Form 8-K
ID: 0001213900-24-056807